Recombinant Human Heart-Type Fatty Acid-Binding Protein as Standard in Immunochemical Assays

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/CCLM.1998.048PMID 9676384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revision of the amino acid sequence of human heart fatty acid-binding protein

  2004cited by this paper
• Fatty acid-binding protein and the early detection of acute myocardial infarction.

  1998cited by this paper
• An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction.

  1997cited by this paper
• One-Step Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma Fatty Acid-Binding Protein

  1997cited by this paper
• Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction.

  1997cited by this paper
• Estimation of Myocardial Infarct Size from Plasma Myoglobin or Fatty Acid-Binding Protein. Influence of Renal Function

  1997cited by this paper
• Cloning, expression, purification, and characterization of the major core protein (p26) from equine infectious anemia virus.

  1997cited by this paper
• Enzyme immunosensor for diagnosis of myocardial infarction

  1996cited by this paper
• Preparation and Characterization of Human Recombinant Protein 1/Clara Cell M r 10 000 Protein

  1996cited by this paper
• Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans.

  1996cited by this paper
• One-step purification of rat heart-type fatty acid-binding protein expressed in Escherichia coli.

  1996cited by this paper
• Differentiation-dependent expression of heart type fatty acid-binding protein in C2C12 muscle cells.

  1996cited by this paper
• Monoclonal antibodies to human heart fatty acid-binding protein.

  1995cited by this paper
• Chapter 10 - Fatty Acid Binding Proteins

  1994cited by this paper
• N-terminal variants of fatty acid-binding protein from bovine heart overexpressed in Escherichia coli.

  1994cited by this paper
• A Rapid Assay for the Quantification of Myoglobin: Evaluation and Diagnostic Relevance in the Diagnosis of Acute Myocardial Infarction

  1994cited by this paper
• Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.

  1994cited by this paper
• Three-dimensional structure of recombinant human muscle fatty acid-binding protein.

  1994cited by this paper
• Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man

  1992cited by this paper
• Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis.

  1992cited by this paper
• Cloning of the cDNA encoding human skeletal-muscle fatty-acid-binding protein, its peptide sequence and chromosomal localization.

  1991cited by this paper
• Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system.

  1991cited by this paper
• High-yield two-step chromatographic procedure for purification of fatty acid-binding protein from human heart.

  1991cited by this paper
• Use of T7 RNA polymerase to direct expression of cloned genes.

  1990cited by this paper
• Engineering proteins for purification.

  1990cited by this paper
• Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assay.

  1989cited by this paper
• Calculation of protein extinction coefficients from amino acid sequence data.

  1989influential reference
• Measurement of rat heart fatty acid binding protein by ELISA. Tissue distribution, developmental changes and subcellular distribution.

  1987cited by this paper
• Isolation and characterization of the fatty acid binding protein from human heart.

  1986cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Modified reagents for determination of urea and ammonia.

  1962cited by this paper

• Formation of molecularly imprinted polymers: Strategies applied for the removal of protein template (review).

  2024cites this paper
• ENZYME-LINKED IMMUNOSORBENT ASSAY OF AUTOANTIBODIES AGAINST HUMAN β1-ADRENERGIC RECEPTOR USING RECOMBINANT ANTIGENS

  2023cites this paper
• Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention

  2019cites this paper
• Novel biomarkers of cardiovascular disease: Applications in clinical practice

  2018cites this paper
• Recombinant horseradish peroxidase: Production and analytical applications

  2015influential citation
• Evaluation Factors of Pulmonary Embolism Severity and Prognosis

  2015cites this paper
• Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndrome.

  2014cites this paper
• Evaluation of Severity and Prognosis of Pulmonary Embolism

  2014cites this paper
• Identification of novel sarcomeric modifiers of hypertrophy in hypertrophic cardiomyopathy using the yeast two-hybrid system

  2013cites this paper
• Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay

  2013cites this paper
• Generation and optimisation of novel recombinant antibodies for improved cardiac diagnostics

  2011cites this paper
• Serum 99th centile values for two heart-type fatty acid binding protein assays

  2009cites this paper
• Serum Chemical Biomarkers of Cardiac Injury for Nonclinical Safety Testing

  2006cites this paper
• The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase–myocardial band

  2006cites this paper
• Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications.

  2006cites this paper
• Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury.

  2005cites this paper
• Fatty acid-binding proteins as plasma markers of tissue injury.

  2005cites this paper
• One-step immunoassay for measuring protein concentrations in plasma, based on precipitate-enhanced ellipsometry.

  2004cites this paper
• Fatty acid-binding protein as plasma marker for tissue injury

  2004cites this paper
• A continuous displacement immunoassay for human heart-type fatty acid-binding protein in plasma.

  2004cites this paper
• Current concepts in standardization of cardiac marker immunoassays

  2004cites this paper
• Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant?

  2003cites this paper
• Comparison of perfusate activities of glutathione S-transferase, alanine aminopeptidase and fatty acid binding protein in the assessment of non-heart-beating donor kidneys

  2003cites this paper
• Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility.

  2003cites this paper
• Standardization of Cardiac Markers

  2003cites this paper
• Fatty Acid Binding Protein as an Early Plasma Marker of Myocardial Ischemia and Risk Stratification

  2003cites this paper
• Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates

  2002cites this paper
• A genetically engineered fusion protein with horseradish peroxidase as a marker enzyme for use in competitive immunoassays.

  2001cites this paper
• Immunosensors in clinical analysis

  2000cites this paper
• Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein.

  2000cites this paper
• Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays.

  1999cites this paper
• Fatty acid binding protein in heart and skeletal muscles of the migratory barnacle goose throughout development.

  1999cites this paper
• Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects.

  1999cites this paper
• Survey of the 1998 optical biosensor literature

  1999cites this paper
• Influence of Age and Sex and Day-to- Day and Within-Day Biological Variation on Plasma Concentrations of Fatty Acid-binding

  1999cites this paper
• Fatty acid binding protein in heart and skeletal muscles of the migratory barnacle goose throughout development

  1999cites this paper
• Fatty acid binding protein in heart and skeletal muscles of the migratory barnacle goose throughout development

  1999cites this paper
• Fatty acid metabolism in human breast cancer cells (MCF7) transfected with heart-type fatty acid binding protein

  1999cites this paper
• On-line flow displacement immunoassay for fatty acid-binding protein.

  1998cites this paper